Decreased serum interleukin‐41/Metrnl levels in patients with Graves' disease-Reference-Cited by-同舟云学术

Decreased serum interleukin‐41/Metrnl levels in patients with Graves' disease

Published:2022-08-29 Issue:10 Volume:36 Page:
ISSN:0887-8013
Container-title:Journal of Clinical Laboratory Analysis
language:en
Short-container-title:Clinical Laboratory Analysis

Author:

Gong Luping¹²,Huang Guoqing¹²,Weng Linjie²,Xu Jialu³,Li Yan¹²,Cui Wugeng¹²,Li Mingcai¹²^ORCID

Affiliation:

1. The Affiliated Hospital of Medical School Ningbo University Ningbo China

2. Zhejiang Key Laboratory of Pathophysiology Ningbo University School of Medicine Ningbo China

3. The Affiliated Lihuili Hospital, Ningbo University Ningbo China

Publisher

Wiley

Subject

Microbiology (medical),Biochemistry (medical),Medical Laboratory Technology,Clinical Biochemistry,Public Health, Environmental and Occupational Health,Hematology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcla.24676

Reference30 articles.

1. Graves’ Disease

2. Serum autotaxin levels are associated with Graves’ disease

3. Low frequency of IL-10-producing B cells and high density of ILC2s contribute to the pathological process in Graves’ disease, which may be related to elevated-TRAb levels

4. Graves’ disease: Epidemiology, genetic and environmental risk factors and viruses

5. Interleukin-21 is associated with disease activity in patients with Graves’ disease

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased serum interleukin-41 correlates with disease severity in myasthenia gravis;International Immunopharmacology;2024-06

2. Homotherapy for heteropathy: Interleukin‐41 and its biological functions;Immunology;2024-04-09

3. Serum Metrnl is Decreased in Metabolic Dysfunction-Associated Fatty Liver Disease: A Case-Control Study;Diabetes, Metabolic Syndrome and Obesity;2024-02

4. Serum interleukin-41 concentrations are decreased in women with rheumatoid arthritis and are not affected by menopausal status, disease activity, or medication;Revista Colombiana de Reumatología;2024-02

5. Interleukin-41 as a biomarker of the anti-inflammatory response associated with hyperuricemia;Immunology Letters;2023-12